02/28/2026
Hypothyroidism & Long-Term Brain Health â What New Research Shows
At DNP Wellness, weâre committed to exploring how comprehensive thyroid care supports whole-body wellness â not just lab numbers.
A large observational study published in The Journal of Clinical Endocrinology & Metabolism found that people with hypothyroidism who were treated with combination therapy (levothyroxine + T3 / liothyronine) experienced significantly lower risks of dementia and all-cause mortality compared with standard levothyroxine (LT4) alone â even when TSH was within the normal range.
Hereâs what the research highlights:
Persistent risks despite normal TSH:
Standard LT4 therapy may normalize TSH, but residual neurological and mortality risks linked to hypothyroidism may remain elevated.
Reduced dementia risk with combination therapy:
Patients receiving T3-containing regimens in this study showed a notable reduction in dementia incidence compared to LT4 alone.
Lower mortality:
Across >1 million individuals analyzed, combination therapy correlated with lower all-cause mortality over long-term follow-up.
Implications for clinical care:
This kind of evidence suggests that individualized thyroid strategies â especially for patients not fully feeling well on LT4 alone â may have meaningful long-term benefits beyond TSH normalization. As always, thyroid therapy should be tailored to the person, not the number.
Ready to explore advanced thyroid optimization? â¨
𩹠Book a consult with DNP Wellness to discuss a personalized approach to your thyroid health and overall metabolic wellbeing.
â
Reference:
BeltrĂŁo FE de L, et al. Treatment of Hypothyroidism That Contains Liothyronine is Associated With Reduced Risk of Dementia and Mortality. The Journal of Clinical Endocrinology & Metabolism (2025).